

Can't fill your Trokendi XR prescription? Learn about alternative medications for epilepsy and migraine prevention, including Qudexy XR and generic Topiramate.
If your pharmacy can't fill your Trokendi XR prescription, you may be wondering what alternatives are available. Whether the issue is stock availability, insurance coverage, or cost, the good news is that there are several other medications that treat the same conditions as Trokendi XR.
In this guide, we'll explain what Trokendi XR is, how it works, and walk you through the best alternatives so you can have an informed conversation with your doctor.
Trokendi XR is the brand name for Topiramate extended-release capsules, made by Supernus Pharmaceuticals. It's an anticonvulsant (also called an antiepileptic drug) that's FDA-approved to treat:
It comes as an extended-release capsule in 25 mg, 50 mg, 100 mg, and 200 mg strengths, taken once daily. The capsules must be swallowed whole — they cannot be opened, crushed, or sprinkled on food.
Topiramate, the active ingredient in Trokendi XR, works through several mechanisms in the brain:
The extended-release formulation in Trokendi XR delivers the medication gradually over 24 hours, allowing for once-daily dosing and steadier blood levels compared to immediate-release Topiramate.
If you can't get Trokendi XR, these are the most common alternatives your doctor may consider. Never switch medications on your own — always talk to your doctor before making any changes to your seizure or migraine treatment.
Generic Topiramate tablets are the most widely available and affordable alternative. They contain the same active ingredient as Trokendi XR but are taken twice daily instead of once.
Generic Topiramate is the same molecule as Trokendi XR, so the efficacy is similar. The main trade-off is convenience — you'll need to remember two doses per day instead of one.
Qudexy XR is another brand-name extended-release Topiramate capsule. Like Trokendi XR, it's taken once daily. However, Qudexy XR capsules can be opened and sprinkled on soft food, which is a significant advantage for patients who have trouble swallowing capsules.
Depakote is an anticonvulsant that works differently from Topiramate. It's FDA-approved for epilepsy and migraine prevention. It increases levels of GABA in the brain and is available as both immediate-release and extended-release tablets.
Lamictal is another widely used anticonvulsant. It's FDA-approved for epilepsy (partial and generalized seizures) and is often used for mood stabilization. While it is not FDA-approved for migraine prevention, it may be considered in certain cases.
If you're considering an alternative to Trokendi XR, here are some questions to bring up with your doctor:
Important: Never stop taking Trokendi XR suddenly. Stopping an anticonvulsant abruptly can cause rebound seizures, even if you've never had seizures before. Your doctor will create a tapering plan if you need to switch.
If you'd prefer to stay on Trokendi XR, there are ways to improve your chances of finding it. Use Medfinder to locate pharmacies with Trokendi XR in stock, and explore savings programs to help with the cost.
Not being able to fill your prescription is stressful, especially for a medication that manages seizures or prevents migraines. But you have options. Generic Topiramate, Qudexy XR, Depakote, and Lamictal are all potential alternatives depending on your specific condition and needs.
Talk to your doctor about which alternative is right for you, and use tools like Medfinder to check availability of any medication in your area. Your treatment doesn't have to stop just because one formulation is hard to find.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.